| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4030150 | Ophthalmology | 2006 | 7 Pages |
Abstract
In this series, high-dose infliximab was a rapidly effective, well-tolerated therapeutic agent for the treatment of chronic, medically refractory, noninfectious uveitis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Philip MD, Michael MD, PhD, Lisa F. MD, Deborah M. MD, MS,